edotreotide has been researched along with o-(2-fluoroethyl)tyrosine in 1 studies
Studies (edotreotide) | Trials (edotreotide) | Recent Studies (post-2010) (edotreotide) | Studies (o-(2-fluoroethyl)tyrosine) | Trials (o-(2-fluoroethyl)tyrosine) | Recent Studies (post-2010) (o-(2-fluoroethyl)tyrosine) |
---|---|---|---|---|---|
206 | 34 | 86 | 124 | 18 | 61 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Combs, SE; Debus, J; Dittmar, A; Dittmar, JO; Giesel, FL; Haberkorn, U; Habermehl, D; Kratochwil, C; Rieken, S; Welzel, T | 1 |
1 other study(ies) available for edotreotide and o-(2-fluoroethyl)tyrosine
Article | Year |
---|---|
First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas.
Topics: Adult; Aged; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neuroimaging; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2017 |